Display Settings:

Format

Send to:

Choose Destination
    Anesth Prog. 1990 Sep-Oct;37(5):223-9.

    Utilization and mechanism of action of tricyclic antidepressants in the treatment of chronic facial pain: a review of the literature.

    Source

    University of Texas Health Science Center, Houston.

    Abstract

    Tricyclic antidepressants show promise in the treatment of chronic facial pain. The antinociceptive activity of this class of drugs appears to be independent of any antidepressant effects. An hypothesis is proposed that tricyclics antidepressants activate a descending serotonergic (5-HT1) antinociceptive pathway which in turn influences endogenous opioids. This antinociceptive pathway appears to utilize an endogenous pain modulation system. Future studies may demonstrate the operative mechanisms of action and open understanding as to etiologic factors.

    PMID:
    2096745
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2148604
    Free PMC Article

      Supplemental Content

      Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk